Who is BlueRock?
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique CELL+GENE™ platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases.
The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel CELL+GENE™ platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology.
What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.
We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.
We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.
Description of Position:
As part of BlueRock Therapeutics vision to change the future of medicine by enabling ground-breaking cell therapies, the candidate will be a key technical contributor of a dynamic and progressive team developing clinical formulations of somatic cell therapies utilizing state-of-the-art technology.
The successful candidate will drive development of clinical cellular drug product formulations at BlueRock, identifying, designing and testing formulations to optimize cell stability and delivery, cell persistence post-transplantation, and enhance the efficacy of the cell therapy. As a central development resource at the company, the clinical formulation development team works closely with product development teams to understand requirements and design clinical delivery formulations for applications in cardiology, neurology and immunology. Expertise in developing clinical formulations for biologics is required, with a strong preference for experience developing cellular medicines. The ideal candidate will be a highly motivated individual who leads from the bench and enjoys having broad responsibilities and opportunities. Collaboration with a highly motivated, world-class team of engineers and scientists promises an exciting and engaging work environment for motivated, self-starting candidates. Familiarity with developing, verifying and qualifying processes and product candidates under GLP or GMP regulations is a plus.